Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S; International Association of Pancreatology.

Pancreatology. 2006;6(1-2):17-32. Review.

2.

Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas.

Furukawa T, Kuboki Y, Tanji E, Yoshida S, Hatori T, Yamamoto M, Shibata N, Shimizu K, Kamatani N, Shiratori K.

Sci Rep. 2011;1:161. doi: 10.1038/srep00161. Epub 2011 Nov 18.

3.

TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.

Rindi G, Falconi M, Klersy C, Albarello L, Boninsegna L, Buchler MW, Capella C, Caplin M, Couvelard A, Doglioni C, Delle Fave G, Fischer L, Fusai G, de Herder WW, Jann H, Komminoth P, de Krijger RR, La Rosa S, Luong TV, Pape U, Perren A, Ruszniewski P, Scarpa A, Schmitt A, Solcia E, Wiedenmann B.

J Natl Cancer Inst. 2012 May 16;104(10):764-77. doi: 10.1093/jnci/djs208. Epub 2012 Apr 23.

PMID:
22525418
5.

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD.

Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9.

6.

Overview of the investigation and management of cystic neoplasms of the pancreas.

Spence RA, Dasari B, Love M, Kelly B, Taylor M.

Dig Surg. 2011;28(5-6):386-97. doi: 10.1159/000334758. Epub 2011 Dec 14. Review.

7.

The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.

Hirono S, Tani M, Kawai M, Okada K, Miyazawa M, Shimizu A, Kitahata Y, Yamaue H.

Ann Surg. 2012 Mar;255(3):517-22. doi: 10.1097/SLA.0b013e3182444231.

PMID:
22301608
8.

Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas.

Matthaei H, Norris AL, Tsiatis AC, Olino K, Hong SM, dal Molin M, Goggins MG, Canto M, Horton KM, Jackson KD, Capelli P, Zamboni G, Bortesi L, Furukawa T, Egawa S, Ishida M, Ottomo S, Unno M, Motoi F, Wolfgang CL, Edil BH, Cameron JL, Eshleman JR, Schulick RD, Maitra A, Hruban RH.

Ann Surg. 2012 Feb;255(2):326-33. doi: 10.1097/SLA.0b013e3182378a18.

9.

The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas.

Khannoussi W, Vullierme MP, Rebours V, Maire F, Hentic O, Aubert A, Sauvanet A, Dokmak S, Couvelard A, Hammel P, Ruszniewski P, Lévy P.

Pancreatology. 2012 May-Jun;12(3):198-202. doi: 10.1016/j.pan.2012.03.056. Epub 2012 Mar 20.

PMID:
22687372
10.

Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease.

Werner J, Fritz S, Büchler MW.

Nat Rev Gastroenterol Hepatol. 2012 Mar 6;9(5):253-9. doi: 10.1038/nrgastro.2012.31. Review.

PMID:
22392299
11.

Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.

Pedrazzoli S, Sperti C, Pasquali C, Bissoli S, Chierichetti F.

Ann Surg. 2011 Dec;254(6):971-6. doi: 10.1097/SLA.0b013e3182383137.

PMID:
22076067
12.

Intraductal papillary mucinous neoplasms of the pancreas: making a disposition using the natural history.

Traverso LW, Moriya T, Hashimoto Y.

Curr Gastroenterol Rep. 2012 Apr;14(2):106-11. doi: 10.1007/s11894-012-0239-7. Review.

PMID:
22278702
13.

Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas.

Hong SM, Omura N, Vincent A, Li A, Knight S, Yu J, Hruban RH, Goggins M.

Clin Cancer Res. 2012 Feb 1;18(3):700-12. doi: 10.1158/1078-0432.CCR-11-1718. Epub 2011 Dec 15.

14.

Management of mucinous cystic neoplasms of the pancreas.

Testini M, Gurrado A, Lissidini G, Venezia P, Greco L, Piccinni G.

World J Gastroenterol. 2010 Dec 7;16(45):5682-92. Review.

15.

Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.

Salvia R, Fernández-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, Pederzoli P, Warshaw AL.

Ann Surg. 2004 May;239(5):678-85; discussion 685-7.

16.

Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas.

Kobayashi N, Sugimori K, Shimamura T, Hosono K, Watanabe S, Kato S, Ueda M, Endo I, Inayama Y, Maeda S, Nakajima A, Kubota K.

Pancreatology. 2012 Mar-Apr;12(2):141-5. doi: 10.1016/j.pan.2011.12.008. Epub 2012 Jan 14.

PMID:
22487524
17.

Solid-pseudopapillary neoplasms of the pancreas: clinical and pathological features of 33 cases.

Cai H, Zhou M, Hu Y, He H, Chen J, Tian W, Deng Y.

Surg Today. 2013 Feb;43(2):148-54. doi: 10.1007/s00595-012-0260-3. Epub 2012 Jul 24.

PMID:
22825652
18.

Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.

Yamaguchi H, Shimizu M, Ban S, Koyama I, Hatori T, Fujita I, Yamamoto M, Kawamura S, Kobayashi M, Ishida K, Morikawa T, Motoi F, Unno M, Kanno A, Satoh K, Shimosegawa T, Orikasa H, Watanabe T, Nishimura K, Ebihara Y, Koike N, Furukawa T.

Am J Surg Pathol. 2009 Aug;33(8):1164-72. doi: 10.1097/PAS.0b013e3181a162e5.

PMID:
19440145
19.

Neuroendocrine neoplasms of the gut and pancreas: new insights.

Rindi G, Wiedenmann B.

Nat Rev Endocrinol. 2011 Aug 2;8(1):54-64. doi: 10.1038/nrendo.2011.120. Review. Erratum in: Nat Rev Endocrinol. 2012 Feb;8(2):66.

PMID:
21808296
20.

Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.

Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB.

Pancreas. 2008 Jan;36(1):50-5. doi: 10.1097/MPA.0b013e31812575df.

PMID:
18192881

Supplemental Content

Support Center